| NCT ID | NCT07683169 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mario Negri Institute for Pharmacological Research |
| Condition | Traumatic Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-10-18 |
| Primary Completion | 2044-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-10-18 with a primary completion date of 2044-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The TRAUMAP study will function as a brain tissue repository for biopsy specimens from patients with traumatic brain injury undergoing brain surgery for contusion removal.
Eligibility Criteria
Inclusion Criteria: * Adults aged ≥18 years. * Diagnosis of traumatic brain injury (TBI). * Admission to the intensive care unit. * Clinical indication for neurosurgical evacuation of a cerebral contusion. * Written informed consent to participate to the study. Exclusion Criteria: * Coagulation disorders or other contraindications to the planned neurosurgical procedure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07683169 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07683169 currently recruiting?
Yes, NCT07683169 is actively recruiting participants. Contact the research team at elisa.zanier@marionegri.it for enrollment information.
Where is the NCT07683169 trial being conducted?
This trial is being conducted at Bergamo, Italy, Monza, Italy.
Who is sponsoring the NCT07683169 clinical trial?
NCT07683169 is sponsored by Mario Negri Institute for Pharmacological Research. The trial plans to enroll 500 participants.